Takeda Pharmaceutical Co Ltd - Company Profile Powered by All the sales intelligence you need on Takeda Pharmaceutical Co Ltd in one solution. Register your interest Save hours of research time with a comprehensive Sales Intelligence Solution. ...
Discovery Company profile page for Takeda Pharmaceutical Co., Ltd. including technical research,competitor monitor,market trends,company profile& stock symbol
Company Profile Takeda Pharmaceutical Co. Ltd. 4-1-1 Dosho-machi Chuo-Ku Osaka, Osaka 540-8645 Phone81 6 620-42111 IndustryPharmaceuticals SectorHealth Care/Life Sciences Fiscal Year-end03/2025 Revenue¥4.26T Net Income¥144.07B 2024 Sales Growth5.87% ...
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medicView full business profile Explore our tools Growth CalculatorBETA Explore the tim...
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medicView full business profile Explore our tools Growth CalculatorBETA Explore the tim...
Profile Card Section Christophe Weber Representative Director - President & CEO VIEW BIO Akiko Amakawa Corporate Strategy Officer & CEO Chief of Staff VIEW BIO Andrew S. Plump Director - President, Research & Development VIEW BIO Asuka Miyabashira President, Japan Pharma Business Unit VIEW ...
Profile Card Section Christophe Weber Representative Director - President & CEO VIEW BIO Akiko Amakawa Corporate Strategy Officer & CEO Chief of Staff VIEW BIO Andrew S. Plump Director - President, Research & Development VIEW BIO Asuka Miyabashira President, Japan Pharma Business Unit VIEW ...
TAK Company ProfileTakeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, ...
“The safety profile of lecanemab reported in clinical practice in the United States, Japan and other countries after launch is consistent with that in the approved labels, and no new safety signals are identified,” Biogen said of the situation last month. The CHMP has specifically backed Leq...
Download Takeda Pharmaceutical Co. Ltd. ADR stock data: historical TAK stock prices from MarketWatch.